Larimar Therapeutics (LRMR) Prepaid Assets (2013 - 2025)
Larimar Therapeutics (LRMR) posted Prepaid Assets of $504000.0 for Q4 2025, up 816.36% on a QoQ basis from $55000.0 in Q3 2025, and down 95.75% year-over-year from $11.8 million in Q4 2024.
Larimar Therapeutics (LRMR) Prepaid Assets (2013 - 2025) Analysis & Trends
Larimar Therapeutics' Prepaid Assets history runs 13 years deep, the most recent figure standing at $504000.0 for Q4 2025.
- Quarterly Prepaid Assets fell 95.75% year-over-year to $504000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $504000.0 (down 95.75% YoY) and the FY2025 annual result came in at $504000.0, down 95.75% from the prior year.
- Prepaid Assets was $504000.0 for Q4 2025 at Larimar Therapeutics, up from $55000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $11.8 million in Q4 2024 and bottomed at $51000.0 in Q3 2023.
- A 5-year average of $2.2 million and a median of $528500.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 18623.53% — and 2025, when it slumped 99.42%.
- Larimar Therapeutics' Prepaid Assets stood at $944000.0 in 2021, then jumped by 144.81% to $2.3 million in 2022, then slumped by 70.49% to $682000.0 in 2023, then jumped by 1637.54% to $11.8 million in 2024, then sank by 95.75% to $504000.0 in 2025.
- Business Quant data shows LRMR's Prepaid Assets at $504000.0 in Q4 2025, $55000.0 in Q3 2025, and $7.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 7.03 Mn |
| Mar 31, 2025 | 379,000.00 |
| Dec 31, 2024 | 11.85 Mn |
| Sep 30, 2024 | 9.55 Mn |
| Jun 30, 2024 | 273,000.00 |
| Mar 31, 2024 | 448,000.00 |
| Dec 31, 2023 | 682,000.00 |
| Sep 30, 2023 | 51,000.00 |
| Jun 30, 2023 | 152,000.00 |
| Mar 31, 2023 | 426,000.00 |
| Dec 31, 2022 | 2.31 Mn |
| Sep 30, 2022 | 957,000.00 |
| Jun 30, 2022 | 186,000.00 |
| Mar 31, 2022 | 553,000.00 |
| Dec 31, 2021 | 944,000.00 |
| Sep 30, 2021 | 3.23 Mn |
| Jun 30, 2021 | 3.41 Mn |
| Mar 31, 2021 | 367,000.00 |